China Biologic's Guizhou Taibang Subsidiary Donates Lifesaving Plasma Products for Injured in Train Disaster near Wenzhou
TAI'AN, China, July 26, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that through its Guizhou Taibang subsidiary, it has donated its life-saving plasma ...
China Biologic Evaluating Possible Effects from a Revised Provincial Plan on Plasma Collection Stations in Guizhou Province
TAI'AN, China, July 15, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the Guizhou Provincial Health Department has issued the revised "Plan for Gui...
China Biologic Evaluating Possible Effects from a Revised Provincial Plan on Plasma Collection Stations in Guizhou Province
TAI'AN, China, July 15, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the Guizhou Provincial Health Department has issued the revised "Plan for Gui...
China Biologic Notified That Guizhou Provincial Government Suspends Implementation of Plan Affecting Plasma Collection Stations
TAI'AN, China, July 13, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the Company has received oral notification from the Guizhou Provincial Health...
China Biologic Notified That Guizhou Provincial Government Suspends Implementation of Plan Affecting Plasma Collection Stations
TAI'AN, China, July 14, 2011 /PRNewswire-Asia/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the Company has received oral notification from the Guizhou Provincial Health Departmen...
China Biologic Products Will Present at the Brean Murray, Carret Conference in Beijing on June 27, 2011
...
China Biologic Products Will Present at Jefferies Global Healthcare Conference in New York on June 9, 2011
TAI'AN, China, June 3, 2011 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will present and meet with investors at the Jefferies 2011 Global Healthcare Conferen...
China Biologic Products to Present at Two Upcoming Investor Conferences
TAI'AN, China, May 13, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will present at two investor conferences in New York City in May 2011. Tri...
China Biologic Products Corrects two Administrative Errors in its May 9, 2011 Earnings Release
TAI'AN, Shandong, China, May 10, 2011 /PRNewswire-Asia/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), today corrected two administrative errors in its earning...
China Biologic Products Reports First Quarter 2011 Results
TAI'AN, China, May 10, 2011 /PRNewswire-Asia/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), today reported record sales and net income for the three months en...
China Biologic Products to Host Earnings Conference Call on May 10, 2011 at 7:30 a.m. EDT (NY)
TAI'AN, China, May 6, 2011 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will host its earnings conference call covering its first quarter 2011 results on May ...
China Biologic Operations to Be Awarded for Outstanding Product and Process Quality
TAI'AN, China, April 12, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (China Biologic" or the "Company") (Nasdaq: CBPO), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced that it has been notified that China Biologic's...
China Biologic Products Reports Record Sales and Net Income for 2010
TAI'AN, SHANDONG PROVINCE, China, April 1, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), today reported record sales and net...
China Biologic Products To Host Earnings Conference Call on April 1, 2011 at 7:00 a.m. EDT
TAI'AN, China, March 31, 2011 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will host its earnings conference call and live webcast covering the year ended Dece...
China Biologic Products Reports Unaudited Preliminary Highlights for the Year 2010
TAI'AN, China, March 17, 2011 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today reported unaudited preliminary financial highlights for the year e...
China Biologic to Present at the Cowen Healthcare Conference
TAI'AN, China, March 4, 2011 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced that Mr. Stanley Lau, President, Dr. Vincent Yi-Wu Xie, Director of Research & Development, a...
China Biologic Products Appoints New Directors
TAI'AN, China, March 3, 2011 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced that effective February 27, 2011, its Board of Directors ...
China Biologic to Acquire Remaining 10% of Guiyang Dalin Biologic Technologies
TAI'AN, China, Jan. 11, 2011 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), today announced that its wholly-owned PRC subsidiary, Logic Managem...
